请使用支持JavaScript的浏览器! Diapharma-Calibrators & Controls-Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml
主营:Chromogenix
banner
当前位置: 首页 > 产品中心 > Calibrators & Controls > Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml

Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml

  • 产品编号: 5090271
  • 美  元  价: $0.00
  • 会  员  价: 待定
  • 品       牌: Diapharma
  • 产       地: 美国
  • 公       司: Diapharma Group, Inc.
  • 产品分类: ref="." class="index">首页 > Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml
  • 公司分类: Calibrators & Controls
:Box/5x1ml
Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml
  • Diapharma/Technoview® Apixaban Control Low/5090271/Box/5x1ml
商品介绍

Description:

Technoview® apixaban control low is a plasma control with a low concentration of apixaban* (~120 ng/ml) for use as a quality control sample in research measurements of apixiban. It is optimized for use with anti-Xa chromogenic assays and is frequently used in conjunction with the Technoview® apixaban high control and the Technoview® apixaban calibrator set in the Technochrom® anti-Xa chromogenic assay.

*Apixaban is the active substance in Eliquis®.

 

 

Advantages:

  • 5 vials per kit- provides control set with a long shelf life
  • Allows for the validation of calibration curves for the measurement of apixaban in plasma
  • Optimized for use with anti-Xa (without exogeneous antithrombin) research assays but can be validated for use in prothrombin time (PT) research assays

Control Set Composition:

  • 5 x 1 ml vials

Control material is lyophilized and prepared from pooled human citrated plasma supplemented with a low concentration of apixaban. The plasma contains stABIlizers but no bactericide additives. It is calibrated, using an anti-Xa assay, in ng/ml against an internal reference standard and in IU/ml against the international standard for low molecular weight (LMWH) in plasma.

 

 

Background:

Apixaban (Eliquis®) is an oral direct factor Xa inhibitor drug. It is prescribed by a healthcare provider and can:

  • reduce the risk of blood clots and stroke in individuals who have nonvalvular atrial fibrillation;
  • treat deep vein thrombosis (DVT) and pulmonary embolism (PE); and
  • reduce the risk of DVT and PE in individuals after hip or knee replacement surgery.

In most cases, apixaban does not require routine monitoring. It typically prolongs clotting tests such as PT/INR and aPTT so, if necessary, it is best measured using an anti-Xa chromogenic assay. Note that this control is for research use only in the US and Canada.

品牌介绍

Mission Statement

Diapharma Group, Inc. in West Chester, Ohio sells hemostasis, thrombosis, platelet function testing, instrumentation, and apoptosis products in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.

diapharma hemostasis chromogenic clotting elisa assay test kit

 

History

The Diapharma Group, Inc. formed on January 1, 1997 from Pharmacia Hepar, Inc. in Franklin, Ohio, and began as the exclusive US and Canadian distributor of the Chromogenix substrates and assays.

Over a quarter-century ago, Chromogenix developed the first chromogenic substrate technology under the former name, Kabi Diagnostica. Kabi later merged with Pharmacia. Some of Diapharma’s current staff worked inside the Chromogenix department within Pharmacia’s heparin manufacturing plant.

In 1998, Diapharma moved to West Chester, Ohio, where it remains today. Over the years, Diapharma expanded its product line to include a variety of hemostasis, cell death, platelet function, ecotoxicology, assays, reagents, antibodies and instruments from superior manufacturers.

In 2017, Diapharma celebrated twenty years of success


自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
在线客服
客服电话

4000-520-616

微信交流